IMHO the study will show some Milds who never prog

IMHO the study will show some Milds who never progressed to moderate,,, will show very little further disease progression symptoms whether in placebo or treatment arm ( that might hurt p value ) .. And that treatment group will never be approved for further treatment anyway. That’s why the different designation explanation in my view .